Bill

Bill > S993


US S993

US S993
Combating Illicit Xylazine Act


summary

Introduced
03/28/2023
In Committee
03/28/2023
Crossed Over
Passed
Dead
01/03/2025

Introduced Session

118th Congress

Bill Summary

A bill to prohibit certain uses of xylazine, and for other purposes.

AI Summary

This bill aims to prohibit the illicit use of xylazine, a substance that is not currently approved by the Food and Drug Administration (FDA) for use in humans. The bill defines xylazine and its various forms, and makes it unlawful for any person to use it in humans or for any use that is not approved by the FDA. The bill also requires the Attorney General, through the Drug Enforcement Administration (DEA), to coordinate with the FDA Commissioner to submit reports to Congress on the prevalence of illicit xylazine use, its impacts, and potential scheduling changes. Additionally, the bill declares illicit xylazine use an "emerging drug threat" in the United States.

Committee Categories

Justice

Sponsors (31)

Last Action

Committee on Banking, Housing, and Urban Affairs. Hearings held. (on 01/11/2024)

Bill Topics

Health
  • ‐ Drug Abuse, Treatment, and Education
Law, Crime, and Family Issues
  • ‐ Illegal Drugs and Narcotics Control

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location Created
State Bill Page https://www.congress.gov/bill/118th-congress/senate-bill/993/all-info 03/29/2023
BillText https://www.congress.gov/118/bills/s993/BILLS-118s993is.pdf 04/11/2023
Loading...